Skip to content

In-Hospital Detection of Elevated Blood Pressure

In-Hospital Detection of Elevated Blood Pressure (INDEBP): Prevalence of New or Uncontrolled Hypertension and Safety of Postponement of Antihypertensive Treatment Adaption in Medical In-patients

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06132451
Acronym
INDEBP
Enrollment
800
Registered
2023-11-15
Start date
2023-11-16
Completion date
2024-12-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, High, Hypertension

Keywords

arterial hypertension, elevated blood pressure, ambulatory blood pressure measurement, antihypertensive medication

Brief summary

The goal of this clinical trial is to analyse the prevalence of new or uncontrolled arterial hypertension (AHT) after hospital discharge of medical in-patients with elevated blood pressure (BP) values during hospitalisation. The main questions it aims to answer are: * Do elevated BP values during hospitalisation correspond to new or uncontrolled AHT after hospital discharge? * Is it safe to postpone adaption of antihypertensive treatment until after proper evaluation of AHT after hospital discharge? Participants will either be treated according to their physicians' decision or antihypertensive treatment adaptions will be postponed until after hospital discharge.

Interventions

OTHERPostponement of antihypertensive treatment

Hypertensive blood pressure values in medical in-patients will not be treated during hospitalisation until confirmed by ABPM 4 weeks after hospital discharge

Sponsors

Annina Vischer
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Caregiver)

Masking description

In the first block, the treating physicians will not be informed about the study participation of their patient, in order to ensure that they will treat the patient according to what they perceive as the current usual practice. In the second block, the treating physicians will be informed about the study participation of their patients.

Intervention model description

There will be block-wise randomization. During the first block, the study team will not interfere with the treating physician, in order to ensure that they will treat the patient according to what they perceive as the current usual practice. During the second block the patients receive no change of their original antihypertensive treatment.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient hospitalized on the internal medicine ward for non-cardiovascular causes, i.e. patients hospitalized for conditions, which are not acutely worsened by uncontrolled AHT * Asymptomatic elevated BP values (defined as 140-180 mmHg systolic and/or 90-110 mmHg diastolic) on at least 2 occasions * Ability to understand study procedures and to provide written informed consent

Exclusion criteria

* Hospitalization for any conditions which can be worsened by uncontrolled AHT: * Cerebrovascular events * Acute coronary syndrome * Acute or decompensated heart failure * Any condition preventing ABPM * Pregnant or lactating women * Failure to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of persisting new or uncontrolled arterial hypertension4 weeks after hospital dischargeElevated blood pressure values in ambulatory blood pressure monitoring
Prevalence of a combined hypertensive complication endpointUntil 4 weeks after hospital dischargeConsisting of intracerebral bleeding, ischemic stroke, myocardial infarction, cardiovascular death or cardiovascular re-hospitalization
Prevalence of a combined hypotensive complication endpointUntil 4 weeks after hospital dischargeConsisting of falls, acute kidney injury, electrolyte disturbances, re-hospitalizations due to hypotension, or BP values on ABPM below the lower treatment limit

Secondary

MeasureTime frameDescription
Prevalence of female genderAt baselineAs reported by participant
Clinic blood pressure measurement in mmHgAt baselineDocumented in the patient documentation
Prevalence of re-hospitalization for any causeUntil 4 weeks after hospital dischargeAccording to hospital documentation and patient interrogation
Research blood pressure measurement in mmHgAt baselineStandardized blood pressure measurement taken by research staff
Prevalence of previously unknown arterial hypertensionAt baselineNo previously documented diagnosis of arterial hypertension and no antihypertensive treatment

Countries

Switzerland

Contacts

Primary ContactAnnina Vischer, M.D.
annina.vischer@usb.ch+41612652525

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026